樱桃视频

October 27, 2016

Cancer survivors take more psych meds than other people

People who live through a bout with cancer are more likely to use medication for anxiety and depression than those without a history of malignancies, a U.S. study suggests.

October 19, 2016

Prostate cancer hormone therapy tied to higher dementia risk

Men who take hormone therapy for prostate cancer may have a higher risk of dementia than patients who receive different treatment for these malignancies, a U.S. study suggests.

October 18, 2016

It's time for a new dialogue about prostate cancer screening

In recent days Ben Stiller made headlines for his courageous and honest account of his prostate cancer diagnosis.

October 13, 2016

Prostate cancer and dementia: Do hormone blockers boost risks?

A large study suggests that hormone-blocking drugs for prostate cancer may increase men's chances for developing dementia.

October 7, 2016

New prostate cancer screening rules fail to curb PSA testing

The number of PSA tests ordered in the U.S. to screen men for prostate cancer hasn't changed in recent years, despite new guidelines that say men shouldn't get this test, a new study finds.

October 7, 2016

Dietary saturated fat linked to aggressive prostate cancer

Men with prostate cancer may be more likely to have the most serious form of the disease if their diet contains a lot of fat from meat and dairy, a recent U.S. study suggests.

October 7, 2016

Ben Stiller's prostate cancer: Do all guys need a PSA test?

Actor Ben Stiller is crediting a prostate cancer screening test for saving his life, revealing today that he was diagnosed and treated for prostate cancer two years ago.

October 4, 2016

Ben Stiller reveals prostate cancer diagnosis

Ben Stiller announced on Tuesday, during an interview on the Howard Stern Show, that he was diagnosed with prostate cancer two years ago when he was 48.

September 30, 2016

Doctors don't communicate well about terminally ill patients

Cancer specialists and primary care physicians are not communicating very well about the end-of-life concerns of the patients they share - and according to one new study, they often rely on those patients to convey information back and forth.

September 27, 2016

Cancer patients may be overly optimistic about early drug trial participation

People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K. So-called phase 1 trials of experimental treatments are intended to test the drug's safety.